

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * COPI coating of Golgi vesicle (GO:0048205) | 7.94941088 |
| 2 | * Golgi transport vesicle coating (GO:0048200) | 7.94941088 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.59211411 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.97313233 |
| 5 | ribosome assembly (GO:0042255) | 5.00719611 |
| 6 | signal peptide processing (GO:0006465) | 4.97689935 |
| 7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.71098388 |
| 8 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.70008764 |
| 9 | positive regulation of nuclease activity (GO:0032075) | 4.65858281 |
| 10 | regulation of nuclease activity (GO:0032069) | 4.25583281 |
| 11 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.24701276 |
| 12 | sequestering of metal ion (GO:0051238) | 4.17918178 |
| 13 | * COPII vesicle coating (GO:0048208) | 4.16335594 |
| 14 | cellular response to unfolded protein (GO:0034620) | 4.09055853 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02713877 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.02713877 |
| 17 | 4-hydroxyproline metabolic process (GO:0019471) | 3.99000755 |
| 18 | protein maturation by protein folding (GO:0022417) | 3.96458734 |
| 19 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.95561274 |
| 20 | cellular response to topologically incorrect protein (GO:0035967) | 3.91401695 |
| 21 | ER-nucleus signaling pathway (GO:0006984) | 3.88617524 |
| 22 | exocrine pancreas development (GO:0031017) | 3.87079049 |
| 23 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.86209253 |
| 24 | proteasome assembly (GO:0043248) | 3.58536280 |
| 25 | desmosome organization (GO:0002934) | 3.55783599 |
| 26 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.52946566 |
| 27 | peptidyl-asparagine modification (GO:0018196) | 3.51337344 |
| 28 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.50438911 |
| 29 | valine metabolic process (GO:0006573) | 3.47006291 |
| 30 | pentose-phosphate shunt (GO:0006098) | 3.45214432 |
| 31 | nuclear pore complex assembly (GO:0051292) | 3.43519540 |
| 32 | establishment of integrated proviral latency (GO:0075713) | 3.42280680 |
| 33 | response to endoplasmic reticulum stress (GO:0034976) | 3.40456476 |
| 34 | ER overload response (GO:0006983) | 3.36193277 |
| 35 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.28092557 |
| 36 | protein N-linked glycosylation (GO:0006487) | 3.25577266 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25303067 |
| 38 | * vesicle coating (GO:0006901) | 3.22472191 |
| 39 | NADPH regeneration (GO:0006740) | 3.16821181 |
| 40 | nuclear pore organization (GO:0006999) | 3.16725393 |
| 41 | response to unfolded protein (GO:0006986) | 3.10862262 |
| 42 | protein autoprocessing (GO:0016540) | 3.10106463 |
| 43 | tRNA aminoacylation for protein translation (GO:0006418) | 3.04853410 |
| 44 | cell adhesion mediated by integrin (GO:0033627) | 3.04604455 |
| 45 | tricarboxylic acid metabolic process (GO:0072350) | 3.03451710 |
| 46 | response to topologically incorrect protein (GO:0035966) | 3.01005839 |
| 47 | regulation of translational termination (GO:0006449) | 2.96340884 |
| 48 | amino acid activation (GO:0043038) | 2.94377020 |
| 49 | tRNA aminoacylation (GO:0043039) | 2.94377020 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93126498 |
| 51 | establishment of viral latency (GO:0019043) | 2.92144031 |
| 52 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.90258390 |
| 53 | regulation of translational fidelity (GO:0006450) | 2.86129508 |
| 54 | peptidyl-proline hydroxylation (GO:0019511) | 2.84656756 |
| 55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.84318653 |
| 56 | endocrine pancreas development (GO:0031018) | 2.84133053 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.78307454 |
| 58 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.74698786 |
| 59 | negative regulation of ligase activity (GO:0051352) | 2.74698786 |
| 60 | formation of translation preinitiation complex (GO:0001731) | 2.72607961 |
| 61 | intestinal cholesterol absorption (GO:0030299) | 2.72534430 |
| 62 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.71085503 |
| 63 | tricarboxylic acid cycle (GO:0006099) | 2.70142202 |
| 64 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.69389560 |
| 65 | cell redox homeostasis (GO:0045454) | 2.68054889 |
| 66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.67168689 |
| 67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.67152402 |
| 68 | proline biosynthetic process (GO:0006561) | 2.66667054 |
| 69 | cellular response to vitamin D (GO:0071305) | 2.65328744 |
| 70 | apoptotic cell clearance (GO:0043277) | 2.64334201 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 2.63954603 |
| 72 | membrane budding (GO:0006900) | 2.63220472 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 2.62987840 |
| 74 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.61692017 |
| 75 | protein targeting to ER (GO:0045047) | 2.61141097 |
| 76 | peptide catabolic process (GO:0043171) | 2.60891935 |
| 77 | regulation of metalloenzyme activity (GO:0048552) | 2.59038712 |
| 78 | * ER to Golgi vesicle-mediated transport (GO:0006888) | 2.58513964 |
| 79 | cotranslational protein targeting to membrane (GO:0006613) | 2.56634886 |
| 80 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55731078 |
| 81 | cysteine metabolic process (GO:0006534) | 2.54530101 |
| 82 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.54217349 |
| 83 | pore complex assembly (GO:0046931) | 2.53685106 |
| 84 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.53197281 |
| 85 | glucose catabolic process (GO:0006007) | 2.53125903 |
| 86 | DNA unwinding involved in DNA replication (GO:0006268) | 2.52468042 |
| 87 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.51346659 |
| 88 | peptide hormone processing (GO:0016486) | 2.51148194 |
| 89 | protein localization to endoplasmic reticulum (GO:0070972) | 2.50023402 |
| 90 | protein hydroxylation (GO:0018126) | 2.48678798 |
| 91 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.46226527 |
| 92 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45452670 |
| 93 | proline metabolic process (GO:0006560) | 2.44964507 |
| 94 | nucleotide-sugar metabolic process (GO:0009225) | 2.44843616 |
| 95 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.44604414 |
| 96 | protein deneddylation (GO:0000338) | 2.44352462 |
| 97 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.44019334 |
| 98 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.43236595 |
| 99 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.42407914 |
| 100 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42407914 |
| 101 | mitochondrial DNA replication (GO:0006264) | 2.42186473 |
| 102 | lysine catabolic process (GO:0006554) | 2.42182748 |
| 103 | lysine metabolic process (GO:0006553) | 2.42182748 |
| 104 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.41081439 |
| 105 | AMP metabolic process (GO:0046033) | 2.40559589 |
| 106 | cellular response to vitamin (GO:0071295) | 2.39996629 |
| 107 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.39764428 |
| 108 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.39764428 |
| 109 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.39764428 |
| 110 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.39641801 |
| 111 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39218390 |
| 112 | L-phenylalanine metabolic process (GO:0006558) | 2.39218390 |
| 113 | DNA strand elongation (GO:0022616) | 2.38863727 |
| 114 | protein carboxylation (GO:0018214) | 2.38713314 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38713314 |
| 116 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.38646508 |
| 117 | hemidesmosome assembly (GO:0031581) | 2.37447211 |
| 118 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.36465158 |
| 119 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.36465158 |
| 120 | protein complex localization (GO:0031503) | 2.34958806 |
| 121 | folic acid metabolic process (GO:0046655) | 2.34727000 |
| 122 | L-phenylalanine catabolic process (GO:0006559) | 2.34572792 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.34572792 |
| 124 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.33954009 |
| 125 | cellular protein complex localization (GO:0034629) | 2.33198124 |
| 126 | intestinal epithelial cell development (GO:0060576) | 2.32222732 |
| 127 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.31086326 |
| 128 | mitotic nuclear envelope reassembly (GO:0007084) | 2.31025009 |
| 129 | nuclear envelope reassembly (GO:0031468) | 2.31025009 |
| 130 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.30668753 |
| 131 | positive regulation of ligase activity (GO:0051351) | 2.30301928 |
| 132 | purine ribonucleotide transport (GO:0015868) | 2.30244486 |
| 133 | skin morphogenesis (GO:0043589) | 2.29334794 |
| 134 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.29078021 |
| 135 | regulation of translational elongation (GO:0006448) | 2.28495182 |
| 136 | alpha-linolenic acid metabolic process (GO:0036109) | 2.28493367 |
| 137 | * Golgi organization (GO:0007030) | 2.28302870 |
| 138 | de novo protein folding (GO:0006458) | 2.27949034 |
| 139 | mitotic metaphase plate congression (GO:0007080) | 2.27900801 |
| 140 | L-serine metabolic process (GO:0006563) | 2.27804445 |
| 141 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.27637722 |
| 142 | tetrahydrofolate metabolic process (GO:0046653) | 2.27119226 |
| 143 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.25611030 |
| 144 | cullin deneddylation (GO:0010388) | 2.24890715 |
| 145 | zinc ion transmembrane transport (GO:0071577) | 2.24770310 |
| 146 | non-recombinational repair (GO:0000726) | 2.24741740 |
| 147 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.20836407 |
| 148 | intestinal absorption (GO:0050892) | 2.18493499 |
| 149 | mitochondrial calcium ion transport (GO:0006851) | 2.17930846 |
| 150 | cellular zinc ion homeostasis (GO:0006882) | 2.17206459 |
| 151 | chaperone-mediated protein folding (GO:0061077) | 2.16288429 |
| 152 | NADP metabolic process (GO:0006739) | 2.14500584 |
| 153 | glandular epithelial cell differentiation (GO:0002067) | 2.12913242 |
| 154 | localization within membrane (GO:0051668) | 2.11220174 |
| 155 | keratan sulfate catabolic process (GO:0042340) | 2.08557931 |
| 156 | cellular response to nutrient (GO:0031670) | 2.08483973 |
| 157 | 2-oxoglutarate metabolic process (GO:0006103) | 2.08220978 |
| 158 | DNA deamination (GO:0045006) | 2.07897187 |
| 159 | serine family amino acid biosynthetic process (GO:0009070) | 2.07631622 |
| 160 | maintenance of protein localization in organelle (GO:0072595) | 2.07278817 |
| 161 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.06004728 |
| 162 | GDP-mannose metabolic process (GO:0019673) | 2.05062286 |
| 163 | positive regulation of glycolytic process (GO:0045821) | 2.04963554 |
| 164 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.03553497 |
| 165 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.03142541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.92882522 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45565593 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.09923632 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.92219854 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.83840528 |
| 6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.65269613 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.52230654 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50807588 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46308403 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.42388689 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25916802 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23565197 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.16309966 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11785577 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09924581 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09802199 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05778760 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04031161 |
| 19 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.94190764 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93630323 |
| 21 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.92954899 |
| 22 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.86953893 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85832635 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.84824189 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.84129221 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81636189 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77900369 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77899666 |
| 29 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.69399425 |
| 30 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66908170 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66084577 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65916941 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63886946 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63621396 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59547242 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58280140 |
| 37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.58175489 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54853419 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53997103 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.50639800 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48662330 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48402107 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46157274 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46003016 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44056846 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44056846 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41622501 |
| 48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41510047 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41138501 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40481021 |
| 51 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.38738029 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.38513297 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38310964 |
| 54 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37579815 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37526345 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37262511 |
| 57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36189737 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35773930 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34407101 |
| 60 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.34150343 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32448304 |
| 62 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31545990 |
| 63 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31439498 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30720375 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30680618 |
| 66 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.29232219 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29048634 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28727569 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27142343 |
| 70 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26552768 |
| 71 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26408355 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26341032 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26098200 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25488740 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25381313 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24642593 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24395390 |
| 78 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23892970 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23089745 |
| 80 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22929369 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22563338 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21739762 |
| 83 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.21073919 |
| 84 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20078125 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18708865 |
| 86 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.18676558 |
| 87 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18666308 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17964156 |
| 89 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17715413 |
| 90 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17121297 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16913683 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16755671 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15578649 |
| 94 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15540614 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15420996 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15328670 |
| 97 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13916342 |
| 98 | MYB_26560356_Chip-Seq_TH2_Human | 1.12860421 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12154694 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11813942 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10913460 |
| 102 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10831353 |
| 103 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.10479474 |
| 104 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10391276 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09922063 |
| 106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09681363 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09257967 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08982855 |
| 109 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08812504 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08796617 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08584836 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08147391 |
| 113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07267047 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06739429 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06422827 |
| 116 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06397489 |
| 117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05956369 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05802973 |
| 119 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05794258 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04653653 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04620733 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04008137 |
| 123 | * MAF_26560356_Chip-Seq_TH1_Human | 1.03395822 |
| 124 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03301447 |
| 125 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03252397 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03207448 |
| 127 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03116915 |
| 128 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02935053 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02637598 |
| 130 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02186464 |
| 131 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.01719948 |
| 132 | MYB_26560356_Chip-Seq_TH1_Human | 1.01661794 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00372439 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00060712 |
| 135 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99331623 |
| 136 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98782950 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98747085 |
| 138 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98556392 |
| 139 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98345978 |
| 140 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98074634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.15167589 |
| 2 | MP0003941_abnormal_skin_development | 3.15167415 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 2.92797187 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.87197275 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.64809600 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.52168053 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.45739872 |
| 8 | MP0005220_abnormal_exocrine_pancreas | 2.39239396 |
| 9 | MP0002796_impaired_skin_barrier | 2.30204844 |
| 10 | MP0005365_abnormal_bile_salt | 2.26600284 |
| 11 | MP0004782_abnormal_surfactant_physiolog | 2.10964193 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.09240180 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.04181235 |
| 14 | MP0009697_abnormal_copulation | 2.00726308 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 1.97223441 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.93036428 |
| 17 | MP0008007_abnormal_cellular_replicative | 1.91877168 |
| 18 | MP0003195_calcinosis | 1.87064879 |
| 19 | MP0010094_abnormal_chromosome_stability | 1.84296990 |
| 20 | MP0008932_abnormal_embryonic_tissue | 1.83471702 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.82222371 |
| 22 | MP0003111_abnormal_nucleus_morphology | 1.80783187 |
| 23 | MP0005360_urolithiasis | 1.76014738 |
| 24 | MP0005501_abnormal_skin_physiology | 1.74207206 |
| 25 | MP0005083_abnormal_biliary_tract | 1.71969577 |
| 26 | MP0005275_abnormal_skin_tensile | 1.71691611 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.70723538 |
| 28 | MP0009840_abnormal_foam_cell | 1.68296821 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.61698211 |
| 30 | MP0001944_abnormal_pancreas_morphology | 1.61116218 |
| 31 | MP0003252_abnormal_bile_duct | 1.58787692 |
| 32 | MP0005257_abnormal_intraocular_pressure | 1.56800228 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.53773254 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.51925889 |
| 35 | MP0001661_extended_life_span | 1.50120960 |
| 36 | MP0002693_abnormal_pancreas_physiology | 1.49471101 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.48799627 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.48683436 |
| 39 | MP0003786_premature_aging | 1.46516048 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.46067610 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.45439362 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.44413323 |
| 43 | MP0000537_abnormal_urethra_morphology | 1.44382102 |
| 44 | MP0003077_abnormal_cell_cycle | 1.40752591 |
| 45 | MP0001730_embryonic_growth_arrest | 1.40303886 |
| 46 | MP0000627_abnormal_mammary_gland | 1.35921726 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.35022391 |
| 48 | MP0004233_abnormal_muscle_weight | 1.30266182 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.27830291 |
| 50 | MP0008058_abnormal_DNA_repair | 1.27469918 |
| 51 | MP0003693_abnormal_embryo_hatching | 1.25359945 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.23855892 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.22434188 |
| 54 | MP0000609_abnormal_liver_physiology | 1.22352405 |
| 55 | MP0005023_abnormal_wound_healing | 1.22033805 |
| 56 | MP0003718_maternal_effect | 1.20547648 |
| 57 | MP0003436_decreased_susceptibility_to | 1.19491366 |
| 58 | MP0003186_abnormal_redox_activity | 1.19075473 |
| 59 | MP0000762_abnormal_tongue_morphology | 1.18250142 |
| 60 | MP0003283_abnormal_digestive_organ | 1.15452620 |
| 61 | MP0002009_preneoplasia | 1.15256004 |
| 62 | MP0004272_abnormal_basement_membrane | 1.15239562 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.13556016 |
| 64 | MP0003868_abnormal_feces_composition | 1.13493372 |
| 65 | MP0002896_abnormal_bone_mineralization | 1.11908960 |
| 66 | MP0004947_skin_inflammation | 1.09135247 |
| 67 | MP0000350_abnormal_cell_proliferation | 1.09049560 |
| 68 | MP0002060_abnormal_skin_morphology | 1.08512120 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.08261096 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.07481941 |
| 71 | * MP0001672_abnormal_embryogenesis/_devel | 1.06924681 |
| 72 | * MP0005380_embryogenesis_phenotype | 1.06924681 |
| 73 | MP0000490_abnormal_crypts_of | 1.06627961 |
| 74 | MP0000358_abnormal_cell_content/ | 1.06464260 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05505826 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.05376167 |
| 77 | * MP0002086_abnormal_extraembryonic_tissu | 1.02799117 |
| 78 | MP0010771_integument_phenotype | 1.01885566 |
| 79 | MP0004043_abnormal_pH_regulation | 1.01584228 |
| 80 | MP0005165_increased_susceptibility_to | 1.00983714 |
| 81 | * MP0002080_prenatal_lethality | 1.00551757 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.99684628 |
| 83 | * MP0003984_embryonic_growth_retardation | 0.99260526 |
| 84 | MP0004957_abnormal_blastocyst_morpholog | 0.98551981 |
| 85 | MP0005408_hypopigmentation | 0.98444581 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.97770457 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.97267605 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.96963465 |
| 89 | MP0000467_abnormal_esophagus_morphology | 0.96489361 |
| 90 | * MP0002088_abnormal_embryonic_growth/wei | 0.96464993 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.96053654 |
| 92 | * MP0001697_abnormal_embryo_size | 0.96041519 |
| 93 | MP0000377_abnormal_hair_follicle | 0.95310674 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.95203889 |
| 95 | MP0001958_emphysema | 0.95007910 |
| 96 | MP0000858_altered_metastatic_potential | 0.94938788 |
| 97 | MP0000685_abnormal_immune_system | 0.94704092 |
| 98 | MP0000598_abnormal_liver_morphology | 0.94544865 |
| 99 | MP0001542_abnormal_bone_strength | 0.94425624 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.94232851 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.94192798 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.93954622 |
| 103 | MP0003795_abnormal_bone_structure | 0.93296350 |
| 104 | MP0005332_abnormal_amino_acid | 0.92609380 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.91814936 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90887221 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.90651203 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.89520349 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.87906644 |
| 110 | MP0001756_abnormal_urination | 0.87540165 |
| 111 | MP0001243_abnormal_dermal_layer | 0.87414387 |
| 112 | MP0002928_abnormal_bile_duct | 0.87093061 |
| 113 | MP0003172_abnormal_lysosome_physiology | 0.86445577 |
| 114 | MP0002118_abnormal_lipid_homeostasis | 0.86406474 |
| 115 | * MP0002084_abnormal_developmental_patter | 0.85271303 |
| 116 | MP0002254_reproductive_system_inflammat | 0.85222218 |
| 117 | MP0002006_tumorigenesis | 0.85111842 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.84997807 |
| 119 | MP0009672_abnormal_birth_weight | 0.84383564 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.84286545 |
| 121 | MP0003279_aneurysm | 0.84276305 |
| 122 | MP0002933_joint_inflammation | 0.84155990 |
| 123 | MP0005451_abnormal_body_composition | 0.82629007 |
| 124 | MP0008260_abnormal_autophagy | 0.82033099 |
| 125 | MP0008469_abnormal_protein_level | 0.81927357 |
| 126 | MP0003724_increased_susceptibility_to | 0.81399986 |
| 127 | MP0010307_abnormal_tumor_latency | 0.81170207 |
| 128 | MP0001881_abnormal_mammary_gland | 0.80666136 |
| 129 | MP0005084_abnormal_gallbladder_morpholo | 0.80602765 |
| 130 | MP0000613_abnormal_salivary_gland | 0.80274284 |
| 131 | MP0000462_abnormal_digestive_system | 0.79431317 |
| 132 | MP0005621_abnormal_cell_physiology | 0.79097444 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.78892803 |
| 134 | MP0009333_abnormal_splenocyte_physiolog | 0.78442856 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.78419960 |
| 136 | MP0000647_abnormal_sebaceous_gland | 0.77933193 |
| 137 | MP0009780_abnormal_chondrocyte_physiolo | 0.76901748 |
| 138 | MP0001873_stomach_inflammation | 0.76733424 |
| 139 | MP0005384_cellular_phenotype | 0.76676883 |
| 140 | MP0000383_abnormal_hair_follicle | 0.76530290 |
| 141 | MP0003959_abnormal_lean_body | 0.76295244 |
| 142 | MP0005503_abnormal_tendon_morphology | 0.74246467 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.74157072 |
| 144 | MP0002396_abnormal_hematopoietic_system | 0.73629088 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.72552018 |
| 146 | MP0009785_altered_susceptibility_to | 0.72302894 |
| 147 | * MP0002085_abnormal_embryonic_tissue | 0.71726267 |
| 148 | MP0001915_intracranial_hemorrhage | 0.71608584 |
| 149 | MP0001853_heart_inflammation | 0.71542826 |
| 150 | MP0000477_abnormal_intestine_morphology | 0.71524003 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.68930818 |
| 152 | MP0003866_abnormal_defecation | 0.67778617 |
| 153 | MP0002419_abnormal_innate_immunity | 0.67316598 |
| 154 | MP0001849_ear_inflammation | 0.65801652 |
| 155 | MP0001835_abnormal_antigen_presentation | 0.64982083 |
| 156 | MP0005390_skeleton_phenotype | 0.63773498 |
| 157 | MP0003303_peritoneal_inflammation | 0.63429799 |
| 158 | MP0005025_abnormal_response_to | 0.63400386 |
| 159 | MP0002136_abnormal_kidney_physiology | 0.62674062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.71329559 |
| 2 | Hypoglycemic seizures (HP:0002173) | 3.80169716 |
| 3 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56861359 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.48489698 |
| 5 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.12967246 |
| 6 | Mucopolysacchariduria (HP:0008155) | 3.12967246 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.10443610 |
| 8 | Cervical subluxation (HP:0003308) | 3.08515389 |
| 9 | Protrusio acetabuli (HP:0003179) | 3.05216199 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.04751437 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.02804399 |
| 12 | Symptomatic seizures (HP:0011145) | 2.99959663 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 2.92929464 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89366929 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 2.89027811 |
| 16 | Thoracolumbar scoliosis (HP:0002944) | 2.86558060 |
| 17 | Premature rupture of membranes (HP:0001788) | 2.82029125 |
| 18 | Ketoacidosis (HP:0001993) | 2.79962046 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72617217 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72617217 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72617217 |
| 22 | Generalized aminoaciduria (HP:0002909) | 2.70175493 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.68664903 |
| 24 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.68371628 |
| 25 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.68371628 |
| 26 | Short nail (HP:0001799) | 2.67052710 |
| 27 | Late onset (HP:0003584) | 2.66777271 |
| 28 | Type I transferrin isoform profile (HP:0003642) | 2.65414100 |
| 29 | Abnormality of the umbilical cord (HP:0010881) | 2.63115015 |
| 30 | Beaking of vertebral bodies (HP:0004568) | 2.59420024 |
| 31 | Tetraparesis (HP:0002273) | 2.57308241 |
| 32 | Selective tooth agenesis (HP:0001592) | 2.50573590 |
| 33 | Hyperglycemia (HP:0003074) | 2.49169074 |
| 34 | Abnormal delivery (HP:0001787) | 2.43935358 |
| 35 | Ketosis (HP:0001946) | 2.39844133 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 2.38597205 |
| 37 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.37173248 |
| 38 | Single umbilical artery (HP:0001195) | 2.37173248 |
| 39 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.37173248 |
| 40 | Intrahepatic cholestasis (HP:0001406) | 2.37084788 |
| 41 | Xanthomatosis (HP:0000991) | 2.35867107 |
| 42 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.35069970 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.34581760 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31275794 |
| 45 | Insulin resistance (HP:0000855) | 2.30543651 |
| 46 | Abnormal cartilage morphology (HP:0002763) | 2.27367698 |
| 47 | Protuberant abdomen (HP:0001538) | 2.27349703 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26927195 |
| 49 | Abdominal distention (HP:0003270) | 2.26788173 |
| 50 | Thrombocytosis (HP:0001894) | 2.24001367 |
| 51 | Sparse eyelashes (HP:0000653) | 2.23799616 |
| 52 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.20303741 |
| 53 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.18767500 |
| 54 | Asymmetry of the thorax (HP:0001555) | 2.18219578 |
| 55 | Abnormal foot bone ossification (HP:0010675) | 2.17824087 |
| 56 | Vascular calcification (HP:0004934) | 2.17020156 |
| 57 | Abnormality of dentin (HP:0010299) | 2.14852779 |
| 58 | Severe short stature (HP:0003510) | 2.14305189 |
| 59 | Onycholysis (HP:0001806) | 2.11876090 |
| 60 | Aortic aneurysm (HP:0004942) | 2.11767784 |
| 61 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10053931 |
| 62 | Cerebral aneurysm (HP:0004944) | 2.09515281 |
| 63 | Deviation of the thumb (HP:0009603) | 2.07938883 |
| 64 | Ankle contracture (HP:0006466) | 2.07696921 |
| 65 | Nonimmune hydrops fetalis (HP:0001790) | 2.07358917 |
| 66 | Microglossia (HP:0000171) | 2.06601758 |
| 67 | Wormian bones (HP:0002645) | 2.06580961 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.04646961 |
| 69 | Abnormal protein glycosylation (HP:0012346) | 2.04646961 |
| 70 | Abnormal glycosylation (HP:0012345) | 2.04646961 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.04646961 |
| 72 | Abnormality of carpal bone ossification (HP:0006257) | 2.04530266 |
| 73 | Trismus (HP:0000211) | 2.03211485 |
| 74 | Osteolytic defects of the hand bones (HP:0009699) | 2.02884686 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02884686 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02807301 |
| 77 | Deep venous thrombosis (HP:0002625) | 1.99887427 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 1.99763287 |
| 79 | Aortic dissection (HP:0002647) | 1.99673139 |
| 80 | Hyperammonemia (HP:0001987) | 1.99521300 |
| 81 | Breech presentation (HP:0001623) | 1.98628056 |
| 82 | Secondary amenorrhea (HP:0000869) | 1.97432541 |
| 83 | Gout (HP:0001997) | 1.97029446 |
| 84 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96982840 |
| 85 | Degeneration of anterior horn cells (HP:0002398) | 1.96007735 |
| 86 | Abnormality of the anterior horn cell (HP:0006802) | 1.96007735 |
| 87 | Vertebral compression fractures (HP:0002953) | 1.95490151 |
| 88 | Vascular tortuosity (HP:0004948) | 1.94283702 |
| 89 | Pili torti (HP:0003777) | 1.93523593 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 1.93204335 |
| 91 | Joint stiffness (HP:0001387) | 1.92764363 |
| 92 | Insidious onset (HP:0003587) | 1.92567237 |
| 93 | Termporal pattern (HP:0011008) | 1.92567237 |
| 94 | Multiple enchondromatosis (HP:0005701) | 1.92348117 |
| 95 | Pterygium (HP:0001059) | 1.92048092 |
| 96 | Microvesicular hepatic steatosis (HP:0001414) | 1.91094925 |
| 97 | Orthostatic hypotension (HP:0001278) | 1.90875031 |
| 98 | Arterial tortuosity (HP:0005116) | 1.90705416 |
| 99 | Hypokinesia (HP:0002375) | 1.87908008 |
| 100 | Abnormality of oral frenula (HP:0000190) | 1.87658309 |
| 101 | Abnormality of purine metabolism (HP:0004352) | 1.86964587 |
| 102 | Peritonitis (HP:0002586) | 1.86669852 |
| 103 | Follicular hyperkeratosis (HP:0007502) | 1.86220013 |
| 104 | Abnormal tarsal ossification (HP:0008369) | 1.86162073 |
| 105 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85837515 |
| 106 | Fat malabsorption (HP:0002630) | 1.85600246 |
| 107 | Elbow flexion contracture (HP:0002987) | 1.83976847 |
| 108 | Ankyloglossia (HP:0010296) | 1.83272396 |
| 109 | Increased cerebral lipofuscin (HP:0011813) | 1.82643365 |
| 110 | Autoamputation (HP:0001218) | 1.82295358 |
| 111 | Abnormal hair laboratory examination (HP:0003328) | 1.81467118 |
| 112 | Abnormality of the lumbar spine (HP:0100712) | 1.81072395 |
| 113 | Microretrognathia (HP:0000308) | 1.80825165 |
| 114 | Entropion (HP:0000621) | 1.80282197 |
| 115 | Hypobetalipoproteinemia (HP:0003563) | 1.80100057 |
| 116 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.79504358 |
| 117 | Platyspondyly (HP:0000926) | 1.79223363 |
| 118 | Breast carcinoma (HP:0003002) | 1.78562504 |
| 119 | Thin bony cortex (HP:0002753) | 1.77395978 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76423139 |
| 121 | Atrophic scars (HP:0001075) | 1.76275568 |
| 122 | Aneurysm (HP:0002617) | 1.75474115 |
| 123 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.74975962 |
| 124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74732628 |
| 125 | Septate vagina (HP:0001153) | 1.74672108 |
| 126 | Proximal placement of thumb (HP:0009623) | 1.73986157 |
| 127 | Radial bowing (HP:0002986) | 1.73208292 |
| 128 | Cupped ribs (HP:0000887) | 1.73050168 |
| 129 | Spastic diplegia (HP:0001264) | 1.71974025 |
| 130 | Steatorrhea (HP:0002570) | 1.71696386 |
| 131 | Abnormality of the calcaneus (HP:0008364) | 1.71182711 |
| 132 | Dry hair (HP:0011359) | 1.69519512 |
| 133 | Soft skin (HP:0000977) | 1.68982695 |
| 134 | Dilatation of the ascending aorta (HP:0005111) | 1.68803828 |
| 135 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.68692146 |
| 136 | Prolonged partial thromboplastin time (HP:0003645) | 1.67702221 |
| 137 | Deep philtrum (HP:0002002) | 1.67618567 |
| 138 | Progressive muscle weakness (HP:0003323) | 1.67469312 |
| 139 | Alopecia of scalp (HP:0002293) | 1.67201856 |
| 140 | Flat acetabular roof (HP:0003180) | 1.66440300 |
| 141 | Back pain (HP:0003418) | 1.65865144 |
| 142 | Redundant skin (HP:0001582) | 1.64866150 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64554972 |
| 144 | Exocrine pancreatic insufficiency (HP:0001738) | 1.64201959 |
| 145 | Shoulder girdle muscle weakness (HP:0003547) | 1.63956454 |
| 146 | Elevated alkaline phosphatase (HP:0003155) | 1.63694467 |
| 147 | Palpitations (HP:0001962) | 1.63388615 |
| 148 | Broad face (HP:0000283) | 1.62754295 |
| 149 | Abnormality of the acetabulum (HP:0003170) | 1.62628741 |
| 150 | Blue sclerae (HP:0000592) | 1.62474728 |
| 151 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.62182396 |
| 152 | Rough bone trabeculation (HP:0100670) | 1.62058519 |
| 153 | Spinal rigidity (HP:0003306) | 1.61963448 |
| 154 | Short humerus (HP:0005792) | 1.61916897 |
| 155 | Curly hair (HP:0002212) | 1.61774988 |
| 156 | Mitral stenosis (HP:0001718) | 1.61739568 |
| 157 | Abnormality of T cell physiology (HP:0011840) | 1.59503237 |
| 158 | Coxa valga (HP:0002673) | 1.57883389 |
| 159 | Metaphyseal cupping (HP:0003021) | 1.57485896 |
| 160 | Hand muscle atrophy (HP:0009130) | 1.56281090 |
| 161 | Pancreatitis (HP:0001733) | 1.56234613 |
| 162 | Hypoplasia of the thymus (HP:0000778) | 1.55619597 |
| 163 | Ovoid vertebral bodies (HP:0003300) | 1.55000653 |
| 164 | Skin nodule (HP:0200036) | 1.54772577 |
| 165 | Epiphyseal dysplasia (HP:0002656) | 1.53080998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.01298964 |
| 2 | TRIB3 | 3.50964702 |
| 3 | SCYL2 | 3.17117472 |
| 4 | PKN2 | 2.88877480 |
| 5 | PBK | 2.88872405 |
| 6 | PASK | 2.84969943 |
| 7 | SRPK1 | 2.77962664 |
| 8 | BCKDK | 2.77593644 |
| 9 | FLT3 | 2.74478282 |
| 10 | NME2 | 2.66002658 |
| 11 | TSSK6 | 2.33272573 |
| 12 | MAP3K12 | 2.19679441 |
| 13 | TTK | 2.09706001 |
| 14 | TAOK3 | 2.03926312 |
| 15 | EIF2AK3 | 1.97866743 |
| 16 | TESK1 | 1.82845115 |
| 17 | FRK | 1.81994948 |
| 18 | ERBB3 | 1.81921384 |
| 19 | LRRK2 | 1.77335583 |
| 20 | SIK1 | 1.69580202 |
| 21 | BCR | 1.66786002 |
| 22 | MAP3K3 | 1.66207573 |
| 23 | PTK6 | 1.64337612 |
| 24 | KDR | 1.60303916 |
| 25 | EEF2K | 1.57498495 |
| 26 | RPS6KA4 | 1.56524832 |
| 27 | TRIM28 | 1.55786083 |
| 28 | INSRR | 1.54164756 |
| 29 | TESK2 | 1.54076747 |
| 30 | BRSK2 | 1.49037416 |
| 31 | JAK3 | 1.38339969 |
| 32 | EPHA2 | 1.38225293 |
| 33 | MYLK | 1.37323352 |
| 34 | MAPKAPK3 | 1.36792428 |
| 35 | ERBB4 | 1.36784565 |
| 36 | PIK3CG | 1.36298446 |
| 37 | TTN | 1.35025959 |
| 38 | FGFR4 | 1.33962470 |
| 39 | PDGFRA | 1.30320089 |
| 40 | PDK2 | 1.29308112 |
| 41 | ACVR1B | 1.29098068 |
| 42 | NEK9 | 1.26613783 |
| 43 | MAP2K3 | 1.25335858 |
| 44 | MAPK15 | 1.23566967 |
| 45 | PLK3 | 1.22131057 |
| 46 | TBK1 | 1.15924061 |
| 47 | PAK4 | 1.15109297 |
| 48 | RPS6KB2 | 1.12992872 |
| 49 | ZAP70 | 1.12306437 |
| 50 | TYK2 | 1.09301307 |
| 51 | STK10 | 1.08827648 |
| 52 | EIF2AK1 | 1.08665748 |
| 53 | MAP3K10 | 1.08261521 |
| 54 | LATS2 | 1.06621063 |
| 55 | MAP3K2 | 1.05542655 |
| 56 | TGFBR1 | 1.05533097 |
| 57 | EPHB1 | 1.00996944 |
| 58 | MET | 0.99806657 |
| 59 | LATS1 | 0.96706815 |
| 60 | RIPK1 | 0.96676945 |
| 61 | HIPK2 | 0.96588221 |
| 62 | EIF2AK2 | 0.96223659 |
| 63 | TGFBR2 | 0.95897333 |
| 64 | SIK3 | 0.95813563 |
| 65 | PIM2 | 0.95467836 |
| 66 | VRK2 | 0.93476354 |
| 67 | STK38L | 0.93054018 |
| 68 | MAP3K8 | 0.92230690 |
| 69 | EPHA3 | 0.91594327 |
| 70 | WEE1 | 0.88418707 |
| 71 | CAMKK2 | 0.88067066 |
| 72 | PTK2 | 0.87479367 |
| 73 | PLK1 | 0.86951658 |
| 74 | PAK2 | 0.85600046 |
| 75 | PLK4 | 0.85236420 |
| 76 | CDK7 | 0.84748803 |
| 77 | MAP2K2 | 0.81436891 |
| 78 | DYRK1B | 0.81028583 |
| 79 | LIMK1 | 0.80644659 |
| 80 | CSNK1A1L | 0.78767069 |
| 81 | DDR2 | 0.78072241 |
| 82 | BTK | 0.77368704 |
| 83 | CSNK1G3 | 0.76223408 |
| 84 | STK24 | 0.75931121 |
| 85 | DYRK3 | 0.75170993 |
| 86 | LMTK2 | 0.74764513 |
| 87 | CDK8 | 0.72562423 |
| 88 | MST1R | 0.71065059 |
| 89 | DAPK1 | 0.70639780 |
| 90 | TEC | 0.70142690 |
| 91 | CSNK1G1 | 0.69287361 |
| 92 | ITK | 0.68687978 |
| 93 | ARAF | 0.67446601 |
| 94 | JAK2 | 0.65727244 |
| 95 | MST4 | 0.65358899 |
| 96 | CDK6 | 0.65084872 |
| 97 | STK39 | 0.64856847 |
| 98 | MAP3K11 | 0.63048078 |
| 99 | MAP4K1 | 0.62758625 |
| 100 | STK3 | 0.62682653 |
| 101 | TAF1 | 0.62639833 |
| 102 | AKT3 | 0.62587216 |
| 103 | IRAK3 | 0.61403832 |
| 104 | STK16 | 0.61254311 |
| 105 | NEK2 | 0.60973190 |
| 106 | BUB1 | 0.60707639 |
| 107 | MAP3K1 | 0.59791845 |
| 108 | TRPM7 | 0.58885767 |
| 109 | MKNK1 | 0.58843967 |
| 110 | KIT | 0.58026872 |
| 111 | JAK1 | 0.57262620 |
| 112 | FER | 0.55685552 |
| 113 | CLK1 | 0.52628803 |
| 114 | ILK | 0.51716798 |
| 115 | PLK2 | 0.51555601 |
| 116 | NEK6 | 0.49490998 |
| 117 | PRKCI | 0.49443815 |
| 118 | MAPK11 | 0.48625833 |
| 119 | SMG1 | 0.48513332 |
| 120 | AURKB | 0.47799598 |
| 121 | AURKA | 0.47282557 |
| 122 | AKT2 | 0.46331500 |
| 123 | PRKG2 | 0.45372830 |
| 124 | ATR | 0.45099609 |
| 125 | BRSK1 | 0.43459112 |
| 126 | CSK | 0.42055484 |
| 127 | CDK4 | 0.41160541 |
| 128 | CDC7 | 0.40605693 |
| 129 | ATM | 0.39678128 |
| 130 | CHEK2 | 0.39634529 |
| 131 | ALK | 0.38634823 |
| 132 | MAP2K1 | 0.38608830 |
| 133 | MTOR | 0.38393412 |
| 134 | FGFR3 | 0.38053177 |
| 135 | FGFR1 | 0.37838060 |
| 136 | NEK1 | 0.37723006 |
| 137 | CHEK1 | 0.37477650 |
| 138 | WNK4 | 0.36655915 |
| 139 | NTRK1 | 0.36472909 |
| 140 | RET | 0.35374455 |
| 141 | PDGFRB | 0.35372077 |
| 142 | PAK3 | 0.35301754 |
| 143 | CSF1R | 0.34727585 |
| 144 | CSNK2A1 | 0.34602029 |
| 145 | CSNK1G2 | 0.33699184 |
| 146 | ABL2 | 0.33043253 |
| 147 | CSNK2A2 | 0.32380973 |
| 148 | CDK9 | 0.31751170 |
| 149 | GSK3A | 0.31228784 |
| 150 | IRAK4 | 0.31035142 |
| 151 | ZAK | 0.29448489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.29319245 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.21790592 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.48116017 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.63773396 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.40598399 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.28582198 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14171413 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.11939368 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03352822 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.94465261 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78049831 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73460861 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65446253 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.65178504 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64239380 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63808640 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55758507 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.55132996 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.54811710 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.53929740 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.52451150 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.51727637 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49972018 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43892414 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43271013 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38831947 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35544762 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35492089 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.32766784 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29063255 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.27958908 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24349548 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.24234352 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.22388650 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20916893 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19044107 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17155260 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.12927243 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11477582 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08283786 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08019177 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.05038888 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03088240 |
| 44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00081707 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99922023 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98935407 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97298778 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96863693 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94190701 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94092847 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91912550 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89134703 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88272826 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87900158 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87073298 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85093623 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.83649211 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.83472908 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81545792 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 0.79960008 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79817323 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78685909 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78563310 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.77952739 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76648770 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76526220 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.75643980 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74263206 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71181730 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70818394 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70611258 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69603008 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68204937 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.68204388 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67486479 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66621717 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66267645 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63440638 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63297783 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.62574061 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61973763 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61129297 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60755546 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60670612 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59952271 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59500893 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59124317 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58732435 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57397276 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57199825 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55117709 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.54169306 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53983904 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53795035 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.52722628 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.52526176 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52407647 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52101110 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.51953475 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51587596 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.51109438 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49678316 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49637946 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.49576316 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49494897 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.48793543 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48685024 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44688197 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.44321454 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44145085 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43585288 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43439760 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43131704 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43089701 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42098087 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40749814 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.39650775 |
| 118 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39123376 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38419579 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38248864 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36712242 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.36690524 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36581690 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.36341329 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34431334 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34029314 |
| 127 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33266845 |
| 128 | Cell cycle_Homo sapiens_hsa04110 | 0.32289666 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32065855 |
| 130 | Mismatch repair_Homo sapiens_hsa03430 | 0.31876839 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31650357 |

